Recap: Anixa Biosciences Q1 Earnings
Portfolio Pulse from Benzinga Insights
Anixa Biosciences (NASDAQ:ANIX) reported Q1 earnings with an EPS of $-0.1, missing estimates by -11.0% and showing no revenue change from the previous year. The company's past earnings miss was followed by a 9.0% share price drop.
March 12, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Anixa Biosciences reported a Q1 EPS of $-0.1, missing estimates by -11.0%, with no revenue change from last year. Previous earnings miss resulted in a 9.0% stock drop.
The reported earnings miss by Anixa Biosciences is likely to negatively impact the stock price in the short term, similar to the previous quarter's earnings miss which resulted in a 9.0% drop in share price the following day. The consistent underperformance in earnings could erode investor confidence and lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100